Holdings of the Fund as of 10/17/2025
Total Number of Holdings (excluding cash): 50
AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
5,788 |
$1,328,751.16 |
7.59% |
Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
6,874 |
$1,328,194.28 |
7.59% |
Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
14,477 |
$1,227,504.83 |
7.01% |
Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
49,185 |
$1,205,524.35 |
6.88% |
Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
25,812 |
$1,126,177.56 |
6.43% |
Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
831 |
$667,151.73 |
3.81% |
Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
5,390 |
$661,945.90 |
3.78% |
Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
1,557 |
$648,973.17 |
3.71% |
Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
4,522 |
$646,646.00 |
3.69% |
Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
4,093 |
$640,186.13 |
3.66% |
Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
2,116 |
$632,281.96 |
3.61% |
Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
1,048 |
$605,796.40 |
3.46% |
United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,363 |
$590,642.42 |
3.37% |
Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
57,716 |
$586,971.72 |
3.35% |
Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,893 |
$560,825.58 |
3.20% |
Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
2,864 |
$389,675.84 |
2.23% |
Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
3,034 |
$289,625.64 |
1.65% |
PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
4,349 |
$286,816.55 |
1.64% |
Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
3,081 |
$269,803.17 |
1.54% |
Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
1,493 |
$266,530.36 |
1.52% |
Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
6,067 |
$238,129.75 |
1.36% |
Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
406 |
$214,396.42 |
1.22% |
Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
9,430 |
$201,990.60 |
1.15% |
BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
3,559 |
$189,659.11 |
1.08% |
Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
5,144 |
$155,657.44 |
0.89% |
Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
2,317 |
$155,308.51 |
0.89% |
Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
1,944 |
$142,086.96 |
0.81% |
Arrowhead Pharmaceuticals, Inc. |
ARWR |
04280A100 |
Biotechnology |
3,763 |
$138,516.03 |
0.79% |
Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
948 |
$132,805.32 |
0.76% |
NewAmsterdam Pharma Company N.V. |
NAMS |
N62509109 |
Biotechnology |
3,446 |
$125,434.40 |
0.72% |
Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
11,366 |
$112,750.72 |
0.64% |
Protagonist Therapeutics, Inc. |
PTGX |
74366E102 |
Biotechnology |
1,404 |
$108,810.00 |
0.62% |
Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
561 |
$106,719.03 |
0.61% |
Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
609 |
$100,947.84 |
0.58% |
Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
4,525 |
$97,830.50 |
0.56% |
TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
2,827 |
$98,012.09 |
0.56% |
Tempus AI, Inc. (Class A) |
TEM |
88023B103 |
Biotechnology |
1,093 |
$95,943.54 |
0.55% |
Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,189 |
$93,562.41 |
0.53% |
Ligand Pharmaceuticals Inc. (Class B) |
LGND |
53220K504 |
Biotechnology |
513 |
$93,186.45 |
0.53% |
Supernus Pharmaceuticals, Inc. |
SUPN |
868459108 |
Pharmaceuticals |
1,837 |
$92,162.29 |
0.53% |
Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
185 |
$89,108.95 |
0.51% |
Rhythm Pharmaceuticals, Inc. |
RYTM |
76243J105 |
Biotechnology |
804 |
$88,665.12 |
0.51% |
BridgeBio Pharma, Inc. |
BBIO |
10806X102 |
Biotechnology |
1,601 |
$87,926.92 |
0.50% |
Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
4,140 |
$85,077.00 |
0.49% |
Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
190 |
$83,391.00 |
0.48% |
Mirum Pharmaceuticals, Inc. |
MIRM |
604749101 |
Biotechnology |
1,123 |
$82,574.19 |
0.47% |
Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,229 |
$80,450.34 |
0.46% |
Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,296 |
$80,468.64 |
0.46% |
ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
4,802 |
$68,956.72 |
0.39% |
ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
3,189 |
$66,618.21 |
0.38% |
US Dollar |
$USD |
|
Other |
42,417 |
$42,416.73 |
0.24% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|